Physician profile
Benjamin Atchie
NPI 1134402415
$35,269.70
in general payments reported to CMS, 2019-2025
16 companies · $3,083 in 2025
The $3,083 reported for 2025 was more than what 93% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,674 · 2020: $7,005 · 2021: $1,188 · 2022: $6,543 · 2023: $10K · 2024: $2,638 · 2025: $3,083.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,000 · Food and Beverage: $7,859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,000.00 |
| Food and Beverage | $7,858.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $9,227.96 | 2019-2025 | Surpass Evolve, Target, Wingspan |
| Medical Device Business Services, INC. | $8,000.00 | 2023 | Cerepak Uniform, Trufill, Pulsar Vascular Pulserider Aneurysm Neck Reconstruction Device |
| Penumbra, INC. | $6,679.78 | 2019-2025 | Penumbra System, Smart Coil, Penumbra Coil 400 |
| Siemens Medical Solutions USA, INC. | $6,575.38 | 2019-2023 | Corpath Imaging System |
| Medtronic, INC. | $2,093.40 | 2021-2025 | Pipeline, Axium Primetm, Rist |
| Depuy Synthes Sales INC. | $1,284.43 | 2021-2025 | Trufill, Cerepak Uniform, N/A |
| Microvention, INC. | $967.18 | 2019-2025 | Stent, Web Aneurysm Embolization System, Scepter C |
| Abbott Laboratories | $142.95 | 2023 | Xact |
| Route 92 Medical, INC. | $101.80 | 2025 | |
| Kaneka Medical America LLC | $64.82 | 2025 | Apheresis Machine |
| Becton, Dickinson and Company | $46.86 | 2024 | Hemosphere |
| Imperative Care, INC | $42.12 | 2022 | |
| Cardiva Medical, INC. | $26.84 | 2021 | |
| Medtronic USA, INC. | $16.18 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$56,369.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Atchie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.